The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). 더 보기
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
NEW YORK, March 2 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) announced today it listed five new exchange traded funds (ETFs) issued by three separate issuers in February, bringing...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.7 | -1.84903197738 | 91.94 | 92.85 | 89.38 | 5853874 | 91.33975746 | SP |
4 | -8.8 | -8.88529886914 | 99.04 | 99.905 | 88.63 | 7807823 | 93.74688729 | SP |
12 | -6.46 | -6.68045501551 | 96.7 | 105.47 | 88.63 | 8320768 | 96.52408419 | SP |
26 | -2.4 | -2.59067357513 | 92.64 | 105.47 | 88.63 | 7811323 | 97.37475538 | SP |
52 | 1.81 | 2.04681669117 | 88.43 | 105.47 | 81.14 | 9112234 | 93.9762988 | SP |
156 | -23.12 | -20.3952011291 | 113.36 | 115.64 | 61.78 | 10033044 | 85.28748821 | SP |
260 | -4.32 | -4.56852791878 | 94.56 | 174.79 | 61.78 | 8443680 | 94.55587706 | SP |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관